My 2c is that the acquisition was primarily for revenues at the target (which was annually $15m). Addl salesforce of course helps for those accounts with no product overlap. On the product front ultramist apparently has synergies with dermapace. In any case the acquisition only just happened so let's see when the numbers are out. Also news on the NASDAQ listing remains pending.
Market Data 
Markets 
